Jingzhou Zhang

No ORCID on file · 1 paper in corpus
observational 2022
BMC cancer ·doi:10.1186/s12885-022-09637-7

BACKGROUND: Cancer antigen 125 (CA125) is clinically used to monitor response to therapy in ovarian cancer and has been proposed for use in detecting ovarian cancer. This population-based study examines how demographic characteristics, gyne…